BIOINFORMA TICS

0'so;112u110}u101q//2duq

SIBumoprOJX

£10"

an?kgowsmomammowoxmoa‘ocgawbmﬁ

 

R.Aguirre-Gamboa and V.Trevino

 

Calin,G.A. and Croce,C.M. (2006) MicroRNA signatures in human cancers. Nat.
Rev. Cancer, 6, 8577866.

Esquela—Kerscher,A. and Slack,F.J. (2006) OncomirsimicroRNAs with a role in
cancer. Nat. Rev. Cancer, 6, 2597269.

Goswami,C.P. and Nakshatri,H. (2012) PROGmiR: a tool for identifying prognos—
tic miRNA biomarkers in multiple cancers using publicly available data. J. Clin.
Bioinforma., 2, 23.

Griffiths—Jones,S. et al. (2006) miRBase: microRNA sequences, targets and gene
nomenclature. Nucleic Acidx' Res, 34, D1407D144.

Healy,N.A. et al. (2012) Systemic mirnas as potential biomarkers for malignancy.
Int. J. Cancer, 131, 221572222.

Kern,S.E. (2012) Why your new cancer biomarker may never work: recurrent patterns
and remarkable diversity in biomarker failures. Cancer Res, 72, 6097$101.

Raponi,M. et al. (2009) MicroRNA classifiers for predicting prognosis of squamous
cell lung cancer. Cancer Res, 69, 577C578}

Reinhart,B.J. et al. (2000) The 21—nucleotide let—7 RNA regulates developmental
timing in Caenorltabditix elegans. Nature, 403, 9017906.

Ruan,K. et al. (2009) MicroRNAs: novel regulators in the hallmarks of human
cancer. Cancer Lett., 285, 11(r126.

Schriml,L.M. et al. (2012) Disease Ontology: a backbone for disease semantic inte—
gration. Nucleic Acids Re.\'., 40, D94(FD946.

Therneau,T.M. and Grambsch,P.M. (2000) Modeling Survival Data: Extending the
Cox Model. Springer, New York.

Wei,R.R. et al. (2013) Clinical significance and prognostic value of microRNA
expression signatures in hepatocellular carcinoma. Clin. Cancer Res, 19,
47804791.

Yu,S.L. et al. (2008) MicroRNA signature predicts survival and relapse in lung
cancer. Cancer Cell, 13, 48757.

Zhu,Y. et al. (2008) GEOmetadb: powerful alternative search engine for the Gene
Expression Omnibus. Bioinformaticx, 24, 2798r800.

 

1632

/810's112um0[p10}x0'sopBLuJOJutotq”:duq

